FDA Investigator: Zhihao Pete Qiu
- Zhihao Pete Qiu first started conducting FDA inspections in 2009, with the last inspection in 2021. Over that time, Zhihao Pete Qiu has conducted 32 inspections at 30 companies across 32 sites.
Documents
FDA 483 SCIL Proteins Production, Halle (Saale) | April 2017
Available - $199
Zhihao Pete Qiu
Human Drug Form 483
FDA 483 Boehringer Ingelheim Pharma & Kg | Nov 2015
Available - $199
Zhihao Pete Qiu
Human Drug Form 483
FDA 483 F. Hoffmann - La Roche, Kaiseraugst | December 2014
Available - $199
Zhihao Pete Qiu
Human Drug Form 483
FDA 483 MSD International GmbH, Singapore | 2021
Out-of-stock
Zhihao Pete Qiu
Human Drug Form 483
FDA 483 FujiFilm Diosynth Biotechnologies U.S.A., Inc., Research Triangle Park | 2021
Out-of-stock
Zhihao Pete Qiu
Human Drug Form 483
FDA 483 Chugai Pharma Manufacturing Co. Ltd., Utsunomiya | 2020
Out-of-stock
Zhihao Pete Qiu
Human Drug Form 483
FDA 483 GP Pharm SA, Sant Quinti De Mediona | 2019
Out-of-stock
Zhihao Pete Qiu
Human Drug Form 483
FDA 483 Immunex Rhode Island Corporation, West Greenwich | 2019
Out-of-stock
Zhihao Pete Qiu
Human Drug Form 483
FDA 483 Amgen Singapore Manufacturing Pte Ltd, Singapore | 2019
Out-of-stock
Zhihao Pete Qiu
Human Drug Form 483
FDA 483 Pfizer Health AB, Strangnas | 2017
Out-of-stock
Zhihao Pete Qiu
Human Drug Form 483
FDA 483 Medalchemy SL, Sant Vicent Del Raspeig | 2017
Out-of-stock
Zhihao Pete Qiu
Human Drug Form 483
FDA 483 UCB Pharma S.A., Braine-l'alleud | 2016
Out-of-stock
Zhihao Pete Qiu
Human Drug Form 483
FDA 483 Baxter Oncology GmbH, Halle (Westf.) | 2016
Out-of-stock
Zhihao Pete Qiu
Human Drug Form 483
FDA 483 Biogen Idec, Inc., Research Triangle Park | 2015
Out-of-stock
Zhihao Pete Qiu
Human Drug Form 483
FDA 483 Patheon Italia S.p.A., Monza | 2015
Out-of-stock
Zhihao Pete Qiu
Human Drug Form 483
FDA 483 Wyeth BioPharma Division of Wyeth Pharmaceuticals, Inc., Andover | 2014
Out-of-stock
Zhihao Pete Qiu
Human Drug Form 483
FDA 483 Lonza Biologics Tuas Pte Ltd, Tuas | 2013
Out-of-stock
Zhihao Pete Qiu
Human Drug Form 483
FDA 483 Bristol Myers Squibb, Devens | 2013
Out-of-stock
Zhihao Pete Qiu
Human Drug Form 483
FDA 483 Human Genome Sciences Inc, Rockville | 2013
Out-of-stock
Zhihao Pete Qiu
Human Drug Form 483
FDA 483 Glaxo Smithkline - Rixensart, Rixensart | 2009
Out-of-stock
Zhihao Pete Qiu
Biologic Form 483
Co-Investigators (23)
- Wendy G. Tan, FDA Investigator
- Seneca D. Toms, FDA Investigator
- Jacek Cieslak, FDA Investigator
- Yun Wu, FDA Investigator
- Cheryl A. Clausen, FDA Investigator
- Ziyang Su, FDA Investigator
- Ephrem T. Hunde, FDA Investigator
- Zhong Li, FDA Investigator
- Wayne E. Seifert, FDA Investigator
- Caryn M. McNab, FDA Investigator
- Haripada Sarker, FDA Investigator
- Thuy T. Nguyen, FDA Investigator
- Roger F. Zabinski, FDA Investigator
- Michael A. Charles, FDA Investigator
- Xiaohui Shen, FDA Investigator
- Laura Fontan, FDA Investigator
- Michael Shanks, FDA Investigator
- Christina A. Capacci-Daniel, FDA Investigator
- Megan A. Haggerty, FDA Investigator
- Bo Chi, FDA Investigator
- Nebil A. Oumer, FDA Investigator
- Donald C. Obenhuber, FDA Investigator
- Sean R. Byrd, FDA Investigator